Jazz Pharmaceuticals acquires pre-clinical pan-RAF inhibitor program from Redx Pharma

Image: Jazz Pharmaceuticals has acquires pre-clinical pan-RAF inhibitor program from Redx Pharma. Photo: courtesy of Bruno Glätsch from Pixabay.